Fudan University: all 1,308 studies
Page 5 of 14. Open to participants first (637), then studies with results posted, then the rest; newest registration first within each.
- clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone MetastasesRecruitingNCT06392217
- Organ Preservation With Tislelizumab and Total Neoadjuvant Therapy in Patients With Low Rectal Cancer: RELIEVE -01 StudyNot yet recruitingNCT06390982Phase 2
- LM-108 in Combination With PD-1 Based Treatment for Patients With Recurrent or Metastatic Triple - Negative Breast CancerRecruitingNCT06387628Phase 2
- Newly Emerging Immunotherapy for Pancreatic Cancer TreatmentNot yet recruitingNCT06370754Phase 1/2
- Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLCRecruitingNCT06369181
- PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence PatientsRecruitingNCT06359275Phase 2
- Real-world Effectiveness and Safety Study of Sacituzumab Govitecan in Chinese Metastatic Breast CancerRecruitingNCT06356519
- Dasatinib Combined With Quercetin to Reverse Chemo Resistance in Triple Negative Breast CancerRecruitingNCT06355037Phase 2
- DV Combined With Toripalimab for Renal Preservation in Solitary Kidney or Renal Insufficiency or Bilateral Multiple UTUCRecruitingNCT06354231Phase 2
- Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung CancerRecruitingNCT06349252
- Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant AbemaciclibRecruitingNCT06341621Phase 3
- A Multicenter, Prospective, Phase II Study of Zanubrutinib for Maintenance in Patients With Mantle Cell LymphomaRecruitingNCT06341556Phase 2
- HAIC Combined With Cadonilimab and Regorafenib as 2nd-line Treatment for ICCRecruitingNCT06335927Phase 2
- Anlotinib With Trastuzumab Deruxtecan for Previously Treated HER2-Low Advanced Breast CancerRecruitingNCT06331169Phase 1
- Adjuvant Target Therapy Guided by ctDNA-MRD in Patients With EGFR-mutant II-IIIA Non-small Cell Lung Cancer (ECTOP-1022)Not yet recruitingNCT06323148Phase 3
- Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell LymphomaRecruitingNCT06314334Phase 2
- Metronomic Capecitabine in Stage III Gastric CancerRecruitingNCT06313567Phase 3
- Surufatinib Combined With Toripalimab and HAIC in the Treatment of Inoperable or Metastatic Intrahepatic CholangiocarcinomaNot yet recruitingNCT06313554Not applicable
- Treatment Response Adapted Hybrid Radiotherapy in Metastatic Non-small Cell Lung Cancer Receiving First-line ImmunotherapyRecruitingNCT06313541Phase 2
- Everolimus Combined With PD-1 in Advanced Colorectal Cancer PatientsNot yet recruitingNCT06301386Phase 2
- The Application of Probe Confocal Laser Endomicroscopy in Pancreatic Tumor SurgeryRecruitingNCT06289803Not applicable
- Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular CarcinomaRecruitingNCT06285019Phase 2
- CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal CancerRecruitingNCT06281405Phase 2
- Effectiveness of Gut Microbiota-targeted Dietary Intervention Among HIV-infected PatientsNot yet recruitingNCT06279819Not applicable
- Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLCRecruitingNCT06258642Not applicable
- A Study on the Prognosis of Two Different Surgery Methods in Patients With Rectal EndometriosisRecruitingNCT06254716
- Radiation and Adebrelimab in Prostate Cancer With Imaging-measurable Disease (RAPID)RecruitingNCT06251492Phase 2
- Radiotherapy to Patients With CA19-9-elevated Advanced Pancreatic CancerRecruitingNCT06250972Phase 3
- mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic Cancer Refractory to ChemotherapyRecruitingNCT06249321Phase 2
- Liquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC )RecruitingNCT06249308
- WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain MetastasesRecruitingNCT06243003Phase 1/2
- Intrathecal Chemotherapy Through Ommaya Reservoir Upon Her-2 Negative Breast Cancer With Leptomeningeal MetastasisRecruitingNCT06230055Phase 4
- Orelabrutinib in the Treatment of HP-positive Gastric MALT LymphomaRecruitingNCT06228963Phase 2
- Effectiveness of Vaccine Chatbot on HPV Vaccine Awareness and Vaccination in ChinaRecruitingNCT06227689Not applicable
- Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal CancerRecruitingNCT06218810Phase 2
- HR070803 in Combination With Oxaliplatin, 5-fluorouracil/LV Versus GX as Adjuvant Therapy for Pancreatic CancerNot yet recruitingNCT06217042Phase 3
- Proteomic Guided First-line Precision Treatment of Renal Clear Cell CarcinomaRecruitingNCT06211790Phase 2
- SHR-A1921 Combined With Bevacizumab in Triple-negative Breast Cancer With Brain MetastasesNot yet recruitingNCT06210438Phase 2
- Predicting Tumor Metastasis by Employing a Target Organ/Primary Lesion Fusion Radiomics ModelRecruitingNCT06202404
- Transcatheter Arterial Infusion to Patients With Advanced Pancreatic CancerRecruitingNCT06196788Phase 2
- Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic CancerNot yet recruitingNCT06196671Phase 2
- A Retrospective and Prospective Real-world Study of Molecular Typing in the Treatment of Advanced Thyroid CancerRecruitingNCT06195228Phase 4
- Local Therapy for Oligometastatic ESCC Patients Treated With PD-1 InhibitorRecruitingNCT06190782Phase 3
- Thoracic Consolidation Radiotherapy for ES-SCLC Treated With Chemo-immunotherapyRecruitingNCT06187740Phase 1
- CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell CarcinomaRecruitingNCT06182735Phase 1
- Tislelizumab Plus GX Versus Tislelizumab Plus GP in the Treatment of R/M NPCRecruitingNCT06177301Phase 3
- DEBIRI Combined With Chemotherapy and Bevacizumab in the Treatment of Unresectable Colorectal Cancer Liver MetastasesNot yet recruitingNCT06177288Not applicable
- Comparison of Kimura Versus Warshaw Technique for Laparoscopic Spleen-Preserving Distal PancreatectomyNot yet recruitingNCT06167421Not applicable
- A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early DetectionRecruitingNCT06166147
- A Study of PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ CancerRecruitingNCT06158919Not applicable
- PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCCRecruitingNCT06156891Phase 2
- PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction ChemotherapyRecruitingNCT06156878Phase 2
- Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic AdenocarcinoNot yet recruitingNCT06156267Early Phase 1
- A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell CarcinomaNot yet recruitingNCT06152978Phase 2
- Assessment of Early Pancreatic Cancer Prognosis by Minimal Residual Disease Using Multi-omics ApproachNot yet recruitingNCT06151691
- mFOLFIRINOX Plus Radiotherapy to Patients With CA19-9-normal Advanced Pancreatic CancerRecruitingNCT06149689Phase 2
- Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ CancerRecruitingNCT06121700Phase 2
- Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally RecurrenceRecruitingNCT06120127Phase 2
- A Study of Surufatinib in the Treatment of Advanced Soft Tissue SarcomaNot yet recruitingNCT06110650Not applicable
- Wedge Resection for Ground-glass Opacity-featured Lung Cancer (ECTOP-1020)Not yet recruitingNCT06102161Phase 3
- Surveillance for Multifocal GGNsRecruitingNCT06097910
- Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination DeficiencyRecruitingNCT06095141Phase 2/3
- Prevention of Recurrence and Metastasis of Colorectal Cancer by Comparing Huaier With Capecitabine MonotherapyRecruitingNCT06090994Phase 4
- A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain MetastasesNot yet recruitingNCT06088056Phase 2
- Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement ScienceRecruitingNCT06085690Not applicable
- Comparison of the Sugarbaker and Keyhole Repair for Parastomal HerniaNot yet recruitingNCT06077318
- Tongxinluo Capsule in the Treatment of Cerebral Small Vessel Disease-A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Study（TOPS-CSVD）Not yet recruitingNCT06061692Phase 4
- Envafolimab Combined With Recombinant Human Endostatin and First-line Chemotherapy Treat of Advanced Mucosal MelanomaNot yet recruitingNCT06041724Phase 2
- Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal CancerRecruitingNCT06039631Phase 2
- Cryoablation Combined with Tislelizumab Plus Lenvatinib in Previously Treated Solid Tumors (CASTLE-11)RecruitingNCT06032845Phase 2
- Selective Lymph Node Dissection for cT1N0M0 Invasive NSCLC With CTR>0.5 Located in the Apical Segment (ECTOP-1018)RecruitingNCT06031246Phase 3
- Sublobar Resection for Adenocarcinoma in Situ/Minimally Invasive Adenocarcinoma Diagnosed by Intraoperative Frozen Section (ECTOP-1019)RecruitingNCT06031181Phase 3
- Study of The Second-line Treatment of Advanced Gastric / Gastroesophageal Junction Adenocarcinoma With Envafolimab and Lenvatinib Combined With Paclitaxel-albuminEnrolling by invitationNCT06030934Phase 2
- Vitamin C to Quality of Life in Patients With Terminal Stage Pancreatic CancerRecruitingNCT06018896Phase 2
- Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic CancerRecruitingNCT06017284Phase 3
- Fruquintinib With mFOLFOX6/FOLFIRI as First-Line Therapy for Conversion Surgery in mCRCRecruitingNCT06010888Phase 2
- PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-IIRecruitingNCT06001099
- A Study of Camrelizumab Plus Chemotherapy in Combination With or Without Famitinib as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (BCTOP-T-N01)RecruitingNCT05999149Phase 3
- Surufatinib as Neoadjuvant Treatment for Locally Advanced or Metastatic Differentiated Thyroid CancerRecruitingNCT05989425Phase 2
- Disitamab Vedotin, Fruquintinib and Tislelizumab in Second-line Treatment for HER2-positive MGCRecruitingNCT05982834Phase 1/2
- Sintilimab Combined With Modified FLOT Regimen in the Treatment of Metastatic Gastric CancerRecruitingNCT05982301Phase 2
- Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian CancerNot yet recruitingNCT05976932
- Effect of Butyphthalide on Cognitive Level Change After Cerebral Vascular Event-a Randomized Control Trial (Be-CLEVER)RecruitingNCT05976152Phase 3
- Adjuvant Serplulimab and Trastuzuma and Chemotherapy in Her-2+ Gastric CancerRecruitingNCT05975749Phase 2
- Regorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRCRecruitingNCT05970705Phase 2
- A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic CancerRecruitingNCT05969171Phase 2
- Suture Repair vs Mesh Repair in the Treatment of Incarcerated Groin Hernia in Elderly PopulationsNot yet recruitingNCT05966285
- Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal CancerRecruitingNCT05963490Phase 2
- Everolimus With Investigator's Choice of Chemotherapy in Advanced Triple-Negative Breast Cancer (TNBC) With Luminal Androgen Receptor (LAR) SubtypeRecruitingNCT05954442Phase 3
- A Study to Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 StudyRecruitingNCT05954429Phase 2
- Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal CancerRecruitingNCT05954078Phase 3
- T-DXd in the First-Line Treatment of Locally Advanced or Metastatic TNBC-LAR HER2-low PatientsNot yet recruitingNCT05953168Phase 2
- Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast CancerRecruitingNCT05949541Phase 2
- Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLMNot yet recruitingNCT05948072Phase 3
- LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic CancerRecruitingNCT05939063Not applicable
- An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC in First-line Treatment (FUTURE-Trop2)Not yet recruitingNCT05928780Phase 1/2
- A Cohort Study of Musculoskeletal Health in Patients With Breast Cancer During Aromatase Inhibitors TherapyRecruitingNCT05921617
- Axillary Surgery De-escalation After Neoadjuvant Therapy Using Dedicate Breast PETRecruitingNCT05914402Not applicable
- Envafolimab Plus Docetaxel In Combination With or Without Trilaciclib Versus Docetaxel in Advanced NSCLCNot yet recruitingNCT05910034Phase 2
- Study of Antivascular Therapy Combined With Chemotherapy Versus Chemotherapy in Adjuvant Therapy of TNBC-BLIS Patients (BCTOP-T-A03)RecruitingNCT05909332Phase 3